Anzeige
Mehr »
Dienstag, 23.09.2025 - Börsentäglich über 12.000 News
Der nächste große KI-Durchbruch in der Frauengesundheit?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EQSP | ISIN: FR001400AXT1 | Ticker-Symbol: J7Y
Frankfurt
22.09.25 | 08:22
3,320 Euro
-0,60 % -0,020
Branche
Konsumgüter
Aktienmarkt
Sonstige
1-Jahres-Chart
VINPAI SA Chart 1 Jahr
5-Tage-Chart
VINPAI SA 5-Tage-Chart

Aktuelle News zur VINPAI Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
11.07.Vinpai Announces Revenue of €4.9 Million for the First Half of 2025293Regulatory News: Vinpai (ISIN: FR001400AXT1; ticker: ALVIN), a specialist in the design, manufacture and marketing of algae- and plant-based functional ingredients for the food and cosmetics...
► Artikel lesen
25.06.Delay in the Timetable for the Acquisition of a Majority Stake in Vinpai and the Filing of a Simplified Tender Offer for Vinpai Shares by Camlin Fine Science Limited286Regulatory News: This press release must not be published, distributed or transmitted, directly or indirectly, in the United States of America, Australia, Canada, South Africa or Japan. CAMLIN...
► Artikel lesen
24.06.Update on the acquisition of a majority stake in Vinpai by Camlin Fine Science Limited280Regulatory News: Vinpai (ISIN: FR001400AXT1; ticker: ALVIN), a specialist in the design, manufacture and marketing of algae- and plant-based functional ingredients for the food and cosmetics...
► Artikel lesen
VINPAI Aktie jetzt für 0€ handeln
25.04.Vinpai Announces Revenue of €2.3 Million for the First Quarter 2025366Backlog1 increases to €5.4 million Regulatory News: Vinpai (ISIN: FR001400AXT1; ticker: ALVIN), a specialist in the design, manufacture and marketing of algae- and plant-based functional ingredients...
► Artikel lesen
02.04.Vinpai Reports its 2024 Full Year Results3692024 revenue growth by 16% to €9.2 million, below the Company targets Gross margin rate at 44%, compared with 48.6% in 2023 EBITDA 2024 came to €-1.8 million and net income to €-2.9...
► Artikel lesen
13.03.Details of the Terms and Conditions of and Timetable for the Acquisition of a Majority Stake in Vinpai by Camlin Fine Science Limited and the Filing of a Simplified Tender Offer for Vinpai Shares by CFSL502Camlin Fine Science Limited and certain significant shareholders of Vinpai, including its founders, have entered into an agreement for the acquisition by CFSL of a majority stake in Vinpai ...
► Artikel lesen
24.02.Signature of an Agreement for the Acquisition of a Majority Stake in Vinpai by Camlin Fine Science Limited420Camlin Fine Science Limited (CFSL) and certain significant shareholders of Vinpai, including its founders, have entered into an agreement for the acquisition by CFSL of a majority stake in Vinpai...
► Artikel lesen
23.01.Vinpai Reports 2024 Sales up 16%, to €9.2 Million3794th quarter 2024 sales of €2.6 million, bringing annual sales to €9.2 million Backlog at €3.8 million as of December 31, 2024 Regulatory News: Vinpai (ISIN: FR001400AXT1; ticker:...
► Artikel lesen
31.10.24Vinpai Reports Its Sales for the 3rd Quarter 2024361Sales of €1.8 million in the 3rd quarter of 2024, bringing sales for the first 9 months of 2024 to €6.5 million, up 7% Recovery in commercial momentum and renewal of the backlog expected...
► Artikel lesen
02.10.24Vinpai Publishes Its 2024 Half Year Results400Growth in restated revenue1 over the 1st half of 2024, up +28.2% compared with 1st half of 2023, to €5.1 million Results reflect development investments Backlog impacted by an unfavorable...
► Artikel lesen
10 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1